PGY2 Transplant Pharmacy Residency Overview
The PGY2 Solid Organ Transplant residency program is designed to develop competencies necessary for independent specialized practice in solid organ transplant, including proficiency in caring for a variety of heart, lung, liver, kidney and pancreas transplant recipients. The primary focus of the residency is the enhancement of patient care, clinical research, and education. Upon completion of this residency, graduates will be prepared to practice as a solid organ transplant pharmacotherapy specialist in an acute or ambulatory care environment.
Tampa General Hospital ranks as one of the busiest transplant programs in the US, with over 200 kidney and kidney/pancreas transplants, 90 liver transplants, 50 heart transplants, and 50 lung transplants performed annually. Additionally, 10 – 15 pediatric kidney transplants are performed each year.
The PGY2 solid organ transplant resident will be an integral part of the health care team for each transplant service, providing comprehensive pharmaceutical care services including pre-transplant evaluations, initial transplant consults, pharmacokinetic analysis, drug information, intensive monitoring and discharge education to patients on service. The resident will also have the opportunity to enhance their precepting skills while serving as a primary preceptor for both rotating students and PGY-1 residents.
In the ambulatory care setting, the resident will gain experience in managing a variety of chronic disease states through time spent with abdominal and cardiothoracic transplant recipients in varying practice models. The PGY2 solid organ transplant preceptors provide a comprehensive educational environment for the transplant resident. These preceptors are integral parts of the various transplant teams, which include a variety of surgical and medical teams focused on providing optimal comprehensive care to newly transplanted and re-admitted transplant recipients. They have a proven commitment to training pharmacists in the management of transplant recipients. Their backgrounds represent a diverse mix of experiences and training:
- Specialty residency training (e.g., critical care, nutrition support, emergency medicine, solid organ transplantation, pediatrics)
- Pharmacy practice residency training
- Board certification
In addition to a focus on direct patient care, preceptors are involved in scholarly activities such as journal publication, textbook publication, scientific journal peer review, clinical research, and platform and poster presentations at various state and national meetings. These practitioners are also actively involved with local, state, national and international professional organizations (e.g., American Society of Transplantation, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, Vizient and International Society of Heart and Lung Transplantation).
Residents completing this residency program will have a variety of teaching responsibilities throughout the year. Formal teaching opportunities include two formal grand rounds presentations to pharmacy staff, student topic discussions, and transplant grand rounds to the transplant department.
Academic teaching opportunities focusing on transplant pharmacotherapy are available through the University of South Florida with over 10 hours of didactic opportunities available. Finally, informal opportunities are numerous, including nursing services and patient/caregiver medication education and counseling.
Residents will serve as co-preceptors for pharmacy students on rotation as well as co-precept any PGY1 residents on transplant rotations.
The PGY2 solid organ transplant resident will become proficient in completing clinical research projects designed to advance transplant pharmacy knowledge and practice. Residents will complete two formal research projects, one in conjunction with a transplant pharmacotherapy specialist designed to be completed and presented at the American Transplant Congress or International Society for Heart and Lung Transplant meeting each spring, and the second to be conducted more independently throughout the residency year, with a goal of publication. In addition to these research projects, quality improvement projects will be completed in conjunction with a transplant pharmacotherapy specialist throughout the year as needs arise.
Residents with a specific interest in publication will have the opportunity to complete and submit a paper for publication during the residency year. Examples of past resident’s publications include review articles as well as publication of major research projects. Finally, residents may present their projects at the following meetings:
- AST Fellowship Symposium
- Vizient Annual Meeting
- Optional: Florida Residency Conference (FRC)
- American Transplant Congress Conference/International Society for Heart and Lung Transplant (if accepted)
- International Society of Heart and Lung Transplant (if accepted)
Residents are trained to independently function as a decentralized, unit-based clinical pharmacist supporting both the pharmacotherapy consult and pharmacy practice service at TGH. The PGY2 solid organ transplant resident will complete their staffing responsibilities on the transplant unit, adult stepdown unit and cardiovascular unit every 4th weekend.
The role and responsibilities of a decentralized, unit-based clinical pharmacist is to support all pharmaceutical services for the patient care area assigned and may include but is not limited to the following:
- Verifying pharmacy orders
- Supporting the pharmacotherapy consult service including pharmacokinetic dosing of medication therapy to include, but not limited to aminoglycosides, vancomycin, warfarin, etc.
- Writing and monitoring orders for TPN.
- Supporting the medication reconciliation service
- Triaging and resolving medication problems
- Responding to code blue team
- Supervising and overseeing pharmacy technicians and students
All residents work one major (Thanksgiving, Christmas or New Year's) and one minor (Labor Day and Memorial Day) holiday throughout the year.
- The resident will complete various clinical rotations and activities at Tampa General Hospital.
- Ambulatory care rotations are conducted at Tampa General Hospital and Tampa General Medical Clinic.
- Academic teaching experiences may be conducted at the University of South Florida College of Pharmacy.
|Core Rotations (10 Months):||Elective Rotations (2 Months):|
Pharmacy Orientation (4 weeks)
Transplant Infectious Diseases
Cardiothoracic Surgery ICU
Pediatric Heart Tx (All Children's Hospital)
- Major and minor research projects
- Transplant Ambulatory Care (6 months abdominal clinic, 6 months cardiothoracic clinic)
- Transplant and pharmacy administration
- Staffing: decentralized, unit-based pharmacist (refer to Staffing Responsibilities)
- Teaching: Pharmacy/Physician/Student teaching.
- Angela T. Logan, PharmD, BCPS
- Lyndsey Bowman-Anger, PharmD, FAST, BCPS
- Andrew Silverman, PharmD, BCPS
- Amy Rumore, PharmD, BCPS
- Andrew Brueckner, PharmD, BCPS
- Patricia Uber, PharmD
- Megan Bloxam, PharmD
|Residency Program||PGY2 Transplant Residency|
|ASHP Program Code||33008|
|Number of Positions||1|
|Application Deadline||January 1st (Please note this program will participate in PhORCAS)|
|Starting Date||July 1|
|Professional Staff||100 pharmacists|
|Non-professional Staff||101 non-pharmacist staff|
|Total Beds (Licensed)||1,007 total beds (948 acute care and 59 rehabilitation care beds)|
|Average Daily Census||765|
- Competitive salary
- Medical insurance (e.g. health, dental)
- Sick leave
- Paid vacation
- Retirement plan contributions
- Professional travel reimbursement
- Lab coats
- Resident office
- Resident computer
- ACLS certification
Please address all correspondence to PGY2 Transplant Residency Director:
Angela T. Logan, PharmD, BCPS
PGY2 Solid Organ Transplant Residency Program Director
Solid Organ Transplant Pharmacotherapy Specialist
Tampa General Hospital